Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA.

ABSTRACT:

SUBMITTER: Della Corte CM 

PROVIDER: S-EPMC7820024 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature